Greenberg Traurig Patent Attorney, Dr. Fang Xie, Speaks at the Trans-Pacific Health Sciences Dialogue at Harvard Medical School

Share Article

On Thursday, Sept. 29, 2016, Dr. Fang Xie, patent attorney and of counsel in Greenberg Traurig, LLP’s Boston office, will be a panelist on the session “Managing Intellectual Property in Asia” at the Trans-Pacific Health Sciences Dialogue conference at Harvard Medical School, Boston.

On Thursday, Sept. 29, 2016, Dr. Fang Xie, patent attorney and of counsel in Greenberg Traurig, LLP’s Boston office, will be a panelist on the session “Managing Intellectual Property in Asia” at the Trans-Pacific Health Sciences Dialogue conference at Harvard Medical School, Boston. During the session, panelists will discuss challenges and opportunities for biotech companies, including retaining US commercialization rights in license deals.

Dr. Xie is co-leader of Greenberg Traurig’s Biotechnology and Pharmaceutical Industry Group within the firm’s global Life Sciences & Medical Technology Group. Recently listed in IAM Strategy 300 – The World’s Leading IP Strategists, Dr. Xie focuses her practice on life sciences & technology‐driven transactions involving the establishing, licensing, sharing, development, and monetization of various intellectual property rights. She has broad experience in worldwide patent and trademark portfolio development, intellectual property due diligence, licensing and technology transfer, patentability and product clearance studies, patent infringement and validity analyses, freedom to operate evaluations, as well as intellectual property litigation and pre-litigation counseling.

About Greenberg Traurig’s Life Sciences & Medical Technology Group

Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing. As part of the group, the Biotechnology and Pharmaceutical Industry Group focuses on advising clients in the biotechnology and pharmaceutical sectors.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 2,000 attorneys serving clients from 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is No. 1 on the 2015 Law360 Most Charitable Firms list, second largest in the U.S. on the 2016 Law360 400, Top 20 on the 2015 Am Law Global 100, and among the 2015 BTI Brand Elite. More information at: http://www.gtlaw.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo-Martinez
@GT_Law
Follow >
Visit website